Prentiss Smith & Co’s Nektar Therapeutics NKTR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17	Closed	-$15K	–	169
2018 Q3	$15K	Hold	17	–	–	0.01%	182
2018 Q2	$12K	Hold	17	–	–	0.01%	196
2018 Q1	$27K	Buy	+17	New	+$27K	0.01%	163